RISK ASSESSMENT OF ADVANCED THERAPY MEDICINAL PRODUCTS

• मुख्य लेखकों: R. N. Alyautdin (लेखक), B. K. Romanov (लेखक), A. N. Yavorsky (लेखक), N. D. Bunyatyan (लेखक), V. A. Merkulov (लेखक), A. N. Mironov (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products», 2018-02-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Advanced therapy medicinal products (ATMP) represent a heterogeneous group of medicinal products, combined with the need for special regulation of their circulation. ATMP is a gene therapy medicinal products, a somatic cell therapy medicinal products, a tissue engineered products and combined ATMPs....